ProQR Therapeutics
PRQR
PRQR
74 hedge funds and large institutions have $365M invested in ProQR Therapeutics in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 24 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
4% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 24
17% less call options, than puts
Call options by funds: $485K | Put options by funds: $584K
Holders
74
Holding in Top 10
1
Calls
$485K
Puts
$584K
Top Buyers
| 1 | +$10.4M | |
| 2 | +$8.74M | |
| 3 | +$4.68M | |
| 4 |
Goldman Sachs
New York
|
+$3.86M |
| 5 |
BlackRock
New York
|
+$3.47M |
Top Sellers
| 1 | -$10.7M | |
| 2 | -$3.49M | |
| 3 | -$2.65M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$1.94M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.69M |